by Taylor D. Brewer
The following bills were passed during the 2017 legislative session:
HB1453/SB848: Authorizes the Department of Behavioral Health and Developmental Services (DBHDS) to train individuals on the administration of Naloxone; authorizes the dispensing of Naloxone by a trained person; and creates immunity from simple negligence for dispensing Naloxone.
HB2317: Authorizes the dispensing and distribution of hypodermic needles and syringes as part of a comprehensive harm-reduction program to be initiated by the Commissioner of Health.
HB2161/SB1179: Directs the Secretary of Health & Human Services to create a workgroup to develop standards and criteria for training healthcare providers on safe and appropriate use of opioids to treat pain and minimize addiction.
HB2165/HB1230: Requires electronic prescriptions for controlled substances containing opioids
HB2164: Adds Gabapentin (Neurontin) to the list of drugs of concern and requires all pharmacies that report Schedule II-IV drugs to the Prescription Monitoring Program to add Gabapentin.
This blog is made available by Goodman Allen Donnelly for general information, and does not constitute legal advice. By reading this blog, you understand that there is no attorney-client relationship between you and the firm. This blog should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.